换一批Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
第一作者：
Linda,Sooman
第一单位：
Rudbeck Laboratory, Department of Radiation, Oncology and Radiation Science, Section of Oncology, Uppsala University, Dag Hammarskjölds väg 20, Uppsala, Sweden. linda.sooman@onkologi.uu.se
作者：
医学主题词
抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苯甲酰胺类(Benzamides);脑肿瘤(Brain Neoplasms);喜树碱(Camptothecin);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);计算生物学(Computational Biology);达卡巴嗪(Dacarbazine);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物协同作用(Drug Synergism);胶质母细胞瘤(Glioblastoma);人类(Humans);微阵列分析(Microarray Analysis);哌嗪类(Piperazines);嘧啶类(Pyrimidines);RNA, 肿瘤(RNA, Neoplasm);受体, Notch(Receptors, Notch);信号传导(Signal Transduction);rac1 GTP结合蛋白质(rac1 GTP-Binding Protein)
DOI
10.1007/s00280-013-2197-7
PMID
23736154
发布时间
2018-12-02
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
